Trial Profile
Clinical Phase I Multiple-Dose Safety Research Study of Oltipraz in Smokers
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Oltipraz (Primary)
- Indications Lung cancer
- Focus Biomarker; Pharmacodynamics
- 09 Sep 2005 New trial record.